Scotia Capital’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,726
| Closed | -$569K | – | 796 |
|
|
2019
Q3 | $569K | Sell |
5,726
-1,195
| -17% | -$114K | 0.01% | 489 |
|
|
2019
Q2 | $640K | Sell |
6,921
-19,520
| -74% | -$1.85M | 0.01% | 482 |
|
|
2019
Q1 | $2.49M | Sell |
26,441
-8,542
| -24% | -$747K | 0.03% | 248 |
|
|
2018
Q4 | $2.24M | Sell |
34,983
-10,126
| -22% | -$747K | 0.03% | 249 |
|
|
2018
Q3 | $4.04M | Sell |
45,109
-18,829
| -29% | -$1.66M | 0.05% | 200 |
|
|
2018
Q2 | $5.67M | Buy |
63,938
+196
| +0.3% | +$16.3K | 0.08% | 150 |
|
|
2018
Q1 | $5.68M | Sell |
63,742
-5,264
| -8% | -$505K | 0.08% | 150 |
|
|
2017
Q4 | $7.2M | Sell |
69,006
-1,412
| -2% | -$159K | 0.1% | 133 |
|
|
2017
Q3 | $10.3M | Buy |
70,418
+961
| +1% | +$131K | 0.15% | 101 |
|
|
2017
Q2 | $9.02M | Buy |
69,457
+12,058
| +21% | +$1.48M | 0.15% | 98 |
|
|
2017
Q1 | $7.15M | Buy |
57,399
+1,986
| +4% | +$238K | 0.12% | 119 |
|
|
2016
Q4 | $6.42M | Sell |
55,413
-4,495
| -8% | -$501K | 0.1% | 142 |
|
|
2016
Q3 | $6.23M | Buy |
59,908
+8,749
| +17% | +$947K | 0.11% | 134 |
|
|
2016
Q2 | $5.05M | Buy |
51,159
+7,934
| +18% | +$821K | 0.1% | 140 |
|
|
2016
Q1 | $4.33M | Sell |
43,225
-12,266
| -22% | -$1.26M | 0.09% | 132 |
|
|
2015
Q4 | $6.65M | Hold |
55,491
| – | – | 0.15% | 110 |
|
|
2015
Q3 | $6M | Buy |
55,491
+1,924
| +4% | +$239K | 0.14% | 117 |
|
|
2015
Q2 | $6.14M | Sell |
53,567
-1,218
| -2% | -$139K | 0.12% | 129 |
|
|
2015
Q1 | $6.32M | Buy |
54,785
+11,826
| +28% | +$1.41M | 0.16% | 102 |
|
|
2014
Q4 | $4.81M | Sell |
42,959
-997
| -2% | -$105K | 0.13% | 117 |
|
|
2014
Q3 | $4.17M | Buy |
43,956
+25,682
| +141% | +$2.32M | 0.09% | 134 |
|
|
2014
Q2 | $3.14M | Sell |
18,274
-10,562
| -37% | -$803K | 0.07% | 157 |
|
|
2014
Q1 | $2.01M | Buy |
28,836
+22,076
| +327% | +$1.75M | 0.04% | 197 |
|
|
2013
Q4 | $571K | Buy |
6,760
+1,000
| +17% | +$79.1K | 0.01% | 345 |
|
|
2013
Q3 | $444K | Buy |
5,760
+860
| +18% | +$60.3K | 0.01% | 350 |
|
|
2013
Q2 | $287K | Buy |
+4,900
| New | +$295K | 0.01% | 373 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Scotia Capital's CELG Position: Q4 2019 in Review
Scotia Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,726 shares — an estimated $569K sold.
Scotia Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $10.3M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Scotia Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Scotia Capital sold 5,726 Celgene Corp shares in Q4 2019, an estimated $569K.
- Scotia Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Scotia Capital's Celgene Corp position peaked at $10.3M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Scotia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.